AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal

Travel Med Infect Dis. 2021 Mar-Apr:40:101989. doi: 10.1016/j.tmaid.2021.101989. Epub 2021 Feb 10.

¹ Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal; National Public Health Laboratory, Kathmandu, Nepal.
² Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal.
³ National Public Health Laboratory, Kathmandu, Nepal.
⁴ Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
⁵ Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
⁶ Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, 243 122, India. Electronic address: [email protected].
⁷ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de Las Americas, Pereira, Risaralda, Colombia; School of Medicine, Universidad Privada Franz Tamayo (UNIFRANZ), Cochabamba, Bolivia. Electronic address: [email protected].

No abstract available

Publication types